Torrent Pharma: USFDA concludes inspection at Vizag facility with zero observations
Ahmedabad: Torrent Pharma has announced that the U.S. Food and Drug Administration (USFDA) has concluded an inspection at the company's manufacturing facility at Vizag, Andhra Pradesh with zero observations.
The facility was inspected from 28-Jul-25 to 01-Aug-25.
Read also: Torrent Pharma seeks CCI clearance to acquire majority stake in JB Pharma in Rs 19500 crore deal
This week, Medical Dialogues team also reported that the company is preparing to introduce both oral and injectable versions of Semaglutide, a blockbuster diabetes and weight loss drug, currently led by Danish pharmaceutical giant Novo Nordisk, following its patent expiry in India in early 2026.
Read also: Torrent Pharma Gears Up to Launch Oral, Injectable Semaglutide in 2026 Post Patent Expiry: Report
Torrent Pharmaceuticals, headquartered in Ahmedabad, Gujarat, is a prominent Indian pharmaceutical company known for developing, manufacturing, and marketing branded and generic medications. It operates across various therapeutic areas, including cardiovascular, central nervous system, and diabetes care, with a strong presence in both regulated and emerging global markets.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.